Porton Pharmasolutions Denmark ApS: Financial statements 2025
CVR: 43082671
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Porton Pharmasolutions Denmark ApS (CVR 43082671) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,705,608 and a net result of DKK 94,702 compared with DKK -1,682,051 the year before. That is a decrease of 28.7% compared with the year before. Equity in the 2025 report amounted to DKK -3,983,464. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,705,608
- Profit/Loss
- DKK 94,702
- Equity
- DKK -3,983,464
- Total Assets
- DKK 1,227,683
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 2.7M | 95K | -4M | 1 |
| 2024 | - | 3.8M | -1.7M | -4.1M | 1 |
| 2023 | - | -282K | -3.3M | -2.4M | 1 |
| 2022 | - | -959K | -3.1M | 932K | 1 |
Official annual report
How creditworthy is Porton Pharmasolutions Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Porton Pharmasolutions Denmark ApS has published its annual report for 2024. Gross profit came to DKK 3,796,289, and the net result was DKK -1,682,051.
About Porton Pharmasolutions Denmark ApS
Porton Pharmasolutions Denmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Pavlos Kouroupis. The company is owned by Porton Pharmaceutical Chemicals GmbH. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 2,705,608 and a net result of DKK 94,702 compared with DKK -1,682,051 the year before. Equity in the 2025 report amounted to DKK -3,983,464.